Matthew Robison, DO
Obstetrics & Gynecology · Idaho Falls, IDNPI 1194757393
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 59.0% of the total. 2025 is the largest year on record at $1,223, more than ten times the $25 reported in 2019.
Across 49 payments — averaging $37.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AbbVie$235
- Astellas Pharma US Inc$233
- Daiichi Sankyo Inc.$44
- Bayer$41
- Coloplast$30
- plus $163 from 8 others
Across 18 payments — averaging $987.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$18K
What the payments were for
- Travel & lodging$97353%
- Food & beverage$74841%
- Education$1005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,074 |
| AbbVie | 13 | $235 |
| Astellas Pharma US Inc | 6 | $233 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Bayer | 2 | $41 |
| Coloplast | 1 | $30 |
| Exeltis, USA Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Amgen | 2 | $26 |
| Therapeuticsmd, Inc. | 2 | $25 |
| Shield Therapeutics Inc | 1 | $17 |
| Novo Nordisk | 1 | $14 |
| Bioventus LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$886
How this compares
$1,821 in reported general payments places this provider in the 65th percentile of 166 obstetrics & gynecology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $1,209 |
| Dicyclomine Hcl | 11 | $295 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Idaho Falls
- Ty EricksonIdaho Falls$286K
- Jeffrey BakerIdaho Falls$18K
- Glenn LeavittIdaho Falls$17K
- Tauni EckersellIdaho Falls$3K
- Jeremy WhitingIdaho Falls$3K
- Steven RobisonIdaho Falls$3K
- Steven AdamsIdaho Falls$2K
- Luke O RourkeIdaho Falls$2K
- Kim CoxPocatello$24K
- Kelly SiudzinskiMeridian$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.